Nancy McGee, VP & GM, U.S. Patient Support Services, IQVIA Jennifer Millard, VP, U.S. Integrated Patient Support Services, IQVIA For patient support leaders, the start of a new calendar year is an ...
A Swiss biotechnology company said it has used the gene-editing technology CRISPR to treat a patient with a dangerous blood disease called beta thalassemia, marking the technology’s first trial run by ...
While digital technologies have reshaped many industries, healthcare is one of the last to rely on faxes and phone calls. This holds true for workflows in physician offices and hospitals, which are ...
Krystal Biotech, Inc. has initiated its Phase 3 clinical trial, named IOLITE, to evaluate KB803, a gene therapy designed to treat and prevent corneal abrasions in patients with dystrophic ...
Clinical trials succeed or stall based on one factor that’s easy to overlook: how well they fit into patients’ lives. The science of the trial may be sound and the protocol may be innovative, but if ...
NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- IO Biotech (IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating therapeutic cancer vaccines based on its T-win ® platform, ...
PARIS--(BUSINESS WIRE)--Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of ...
NKGen Biotech’s autologous clinical program product candidate, SNK01, demonstrated improvement in neuroinflammation and cognitive function in patients with Alzheimer’s Disease (“AD”) in its Phase 1 ...
BEIJING, Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results